drugset / Trial / NCT00051545

Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma

NCT00051545 ↗

Phase 3 Terminated 608 enrolled LEO Pharma
RandomizedParallel-groupDouble-blindOther

Summary

To evaluate the efficacy of Seocalcitol in prolonging time to relapse following intended curative resection or percutaneous ablative treatment, i.e. percutaneous ethanol injection(s), percutaneous acetic acid injection(s), percutaneous microwave coagulation therapy, or percutaneous radiofrequency ablation for hepatocellular carcinoma (HCC).

Timeline

Start
1999-11
Primary completion
—
Completion
2004-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Seocalcitol Small molecule 5 ug —

Indications